Zoetis Inc. (ZTS) Stake Increased by Retirement Systems of Alabama
Retirement Systems of Alabama boosted its stake in shares of Zoetis Inc. (NYSE:ZTS) by 7.6% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 250,380 shares of the company’s stock after buying an additional 17,650 shares during the period. Retirement Systems of Alabama’s holdings in Zoetis were worth $13,022,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its stake in Zoetis by 6.5% in the second quarter. Vanguard Group Inc. now owns 29,819,968 shares of the company’s stock valued at $1,415,256,000 after buying an additional 1,812,428 shares during the period. Independent Franchise Partners LLP boosted its stake in Zoetis by 1.6% in the third quarter. Independent Franchise Partners LLP now owns 11,361,033 shares of the company’s stock valued at $590,887,000 after buying an additional 177,286 shares during the period. Principal Financial Group Inc. boosted its stake in Zoetis by 0.9% in the second quarter. Principal Financial Group Inc. now owns 9,890,168 shares of the company’s stock valued at $469,388,000 after buying an additional 92,034 shares during the period. Marshall Wace LLP boosted its stake in Zoetis by 1.9% in the second quarter. Marshall Wace LLP now owns 9,159,978 shares of the company’s stock valued at $434,733,000 after buying an additional 173,902 shares during the period. Finally, Massachusetts Financial Services Co. MA boosted its stake in Zoetis by 114.1% in the second quarter. Massachusetts Financial Services Co. MA now owns 8,738,248 shares of the company’s stock valued at $414,717,000 after buying an additional 4,656,765 shares during the period. 92.41% of the stock is owned by institutional investors.
Zoetis Inc. (NYSE:ZTS) traded up 0.46% on Wednesday, reaching $50.68. The company’s stock had a trading volume of 1,862,887 shares. The company has a market cap of $25.03 billion, a P/E ratio of 36.54 and a beta of 1.05. The stock’s 50 day moving average price is $50.03 and its 200 day moving average price is $49.67. Zoetis Inc. has a 12 month low of $38.26 and a 12 month high of $53.14.
Zoetis (NYSE:ZTS) last released its earnings results on Wednesday, November 2nd. The company reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.06. Zoetis had a return on equity of 72.96% and a net margin of 14.10%. The firm earned $1.20 billion during the quarter, compared to analysts’ expectations of $1.22 billion. During the same period in the prior year, the company earned $0.50 earnings per share. The company’s quarterly revenue was up 2.2% on a year-over-year basis. Equities research analysts forecast that Zoetis Inc. will post $1.94 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 1st. Shareholders of record on Thursday, November 3rd will be paid a dividend of $0.095 per share. This represents a $0.38 annualized dividend and a yield of 0.75%. The ex-dividend date of this dividend is Tuesday, November 1st. Zoetis’s payout ratio is presently 27.54%.
ILLEGAL ACTIVITY NOTICE: This piece was reported by Daily Political and is owned by of Daily Political. If you are viewing this piece on another publication, it was copied illegally and reposted in violation of US & international copyright and trademark laws. The correct version of this piece can be read at http://www.dailypolitical.com/2016/11/30/zoetis-inc-zts-stake-increased-by-retirement-systems-of-alabama.html.
Several equities research analysts have recently commented on ZTS shares. Jefferies Group reissued a “buy” rating and issued a $60.00 target price on shares of Zoetis in a research note on Tuesday, August 23rd. Zacks Investment Research cut Zoetis from a “buy” rating to a “hold” rating in a research note on Thursday, October 6th. Guggenheim reissued a “positive” rating and issued a $60.00 target price on shares of Zoetis in a research note on Monday, August 22nd. Stifel Nicolaus reissued a “buy” rating and issued a $58.00 target price on shares of Zoetis in a research note on Wednesday, October 12th. Finally, JPMorgan Chase & Co. restated a “hold” rating and issued a $53.00 price target on shares of Zoetis in a research report on Thursday, November 3rd. Two analysts have rated the stock with a sell rating, four have issued a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company’s stock. Zoetis currently has a consensus rating of “Buy” and a consensus price target of $55.92.
In other Zoetis news, Director Michael B. Mccallister bought 2,000 shares of the business’s stock in a transaction on Tuesday, September 6th. The stock was purchased at an average cost of $51.34 per share, for a total transaction of $102,680.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Kristin C. Peck sold 10,092 shares of the company’s stock in a transaction on Tuesday, November 22nd. The stock was sold at an average price of $49.55, for a total value of $500,058.60. Following the sale, the insider now owns 22,768 shares of the company’s stock, valued at $1,128,154.40. The disclosure for this sale can be found here. Company insiders own 0.05% of the company’s stock.
Zoetis Company Profile
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a diversified business, marketing products across over eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock), and dogs, cats and horses (collectively, companion animals), and within over five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS).
Receive News & Ratings for Zoetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc. and related companies with MarketBeat.com's FREE daily email newsletter.